Trump's Executive Order: A Free Market Approach to Reducing Prescription Drug Prices

Strategic Insights -

President Donald Trump's new executive order aims to reduce prescription drug prices by addressing a meaningful area for change. The order focuses on a free market approach, which is uncommon in the second Trump administration. Trump has threatened consequences for companies that don't comply, and while it's not a perfect attempt, it should be supported. The order gives administration officials 30 days to create price targets that are meant to "communicate most-favored-nation price targets to pharmaceutical manufacturers to bring prices for American patients in line with comparably developed nations."

Key Takeaways:

  • The Trump administration's executive order aims to reduce prescription drug prices by targeting a meaningful area for change, specifically the free market approach.
  • The order has no legal force but threatens consequences for companies that don't comply, which is a departure from Trump's typical approach of government intervention.
  • The order gives administration officials 30 days to create price targets that are meant to "communicate most-favored-nation price targets to pharmaceutical manufacturers to bring prices for American patients in line with comparably developed nations."
  • Importing prescription drugs from developed nations with low-cost prescription drugs could bring prices closer to what they are in other nations.
  • The term for imports from other nations would be the standard rather than a negotiating tool.
  • The order proposes regulatory action against drug companies if "significant progress" has not been made toward the price targets.
  • The potential implications of the order include lifting import restrictions on FDA-approved drugs and examining the terms of drug patents to bring costs more in line with those of other nations.
  • The order has been welcomed by conservatives, who were expecting price controls.
  • Trump's approach is different from his previous policies, which have favored government intervention.

Statistics:

  • It can cost as much as $4.46 billion to bring a new drug to market.
  • 90% of drugs don't end up making it to market due to the regulatory burden.
  • The lengthy patent protections for drug manufacturers give them the authority to charge artificially high prices.
  • Americans pay more for prescription drugs than people in other countries.

Sources:

  • Trump, Donald. Executive Order. USA TODAY.
  • [Source 1 - Dace Potas, "Opinion: Trump's executive order a start, but more needed to bring down prescription drug prices"]
  • [Source 2 - Dace Potas, "USA TODAY columnist"]